Carlos A. Scrideli

3900, Bandeirantes Avenue
Ribeirao Preto, SP 14049900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

OCT4 and NANOG are involved in adrenocortical tumorigenesis.

OCT4 and NANOG are involved in adrenocortical tumorigenesis.

Journal: Archives of endocrinology and metabolism

Published: May 26, 2026

Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies.

Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies.

Journal: Cerebellum (London, England)

Published: May 18, 2026

Challenging anatomical paradigms: unexpected supratentorial localization of posterior fossa B ependymomas identified by DNA methylation.

Challenging anatomical paradigms: unexpected supratentorial localization of posterior fossa B ependymomas identified by DNA methylation.

Journal: Acta neuropathologica communications

Published: April 08, 2026

Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion.

Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion.

Journal: Pediatric blood & cancer

Published: March 23, 2026

CD123-Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation.

CD123-Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation.

Journal: Pediatric blood & cancer

Published: July 03, 2025

Pain as an Adverse Event During Chemotherapy in Children with Acute Lymphoblastic Leukemia: A Cross-Sectional Nationwide Study.

Pain as an Adverse Event During Chemotherapy in Children with Acute Lymphoblastic Leukemia: A Cross-Sectional Nationwide Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: May 21, 2025

miR-512-3p as a Potential Biomarker of Poor Outcome in Pediatric Medulloblastoma.

miR-512-3p as a Potential Biomarker of Poor Outcome in Pediatric Medulloblastoma.

Journal: Cerebellum (London, England)

Published: February 25, 2025

Utilizing Viral Metagenomics to Characterize Pathogenic and Commensal Viruses in Pediatric Patients with Febrile Neutropenia.

Utilizing Viral Metagenomics to Characterize Pathogenic and Commensal Viruses in Pediatric Patients with Febrile Neutropenia.

Journal: Viruses

Published: February 06, 2025

Neonatal leukemia harboring KAT6A::EP300 fusion: To treat or not to treat?

Neonatal leukemia harboring KAT6A::EP300 fusion: To treat or not to treat?

Journal: Pediatric blood & cancer

Published: September 09, 2024

Impact of a serious immersive virtual reality game in managing pain during venous or catheter procedures in Pediatric Oncology.

Impact of a serious immersive virtual reality game in managing pain during venous or catheter procedures in Pediatric Oncology.

Journal: Einstein (Sao Paulo, Brazil)

Published: August 19, 2024

Identifying prognostic hub genes and key pathways in pediatric adrenocortical tumors through RNA sequencing and Co-expression analysis.

Identifying prognostic hub genes and key pathways in pediatric adrenocortical tumors through RNA sequencing and Co-expression analysis.

Journal: Molecular and cellular endocrinology

Published: July 24, 2024

YAP1 Is a Prognostic Marker and Its Inhibition Reduces Tumor Progression in Adrenocortical Tumors.

YAP1 Is a Prognostic Marker and Its Inhibition Reduces Tumor Progression in Adrenocortical Tumors.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 15, 2024

Showing 1-12 of 112

Last Updated: 09/26/2026